Reporters
-
{
- All
- News
- Videos
-
Arvind Fashions To NALCO: Motilal Oswal Reviews Q2 Results Of Nine Stocks, Check Target Prices
Motilal Oswal Financial Services has reviewed the second-quarter earnings of nine companies across the textile, FMCG, metals and EPC sector including Gopal Snacks, Arvind Fashions, Ventive Hospitality, ConCor, Prataap Snacks, and more
-
Himadri Speciality Shares In Focus As Motilal Oswal Initiates Coverage, Sees Up To 47% Upside; Check Target Price
Motilal Oswal expects Himadri to deliver strong growth, driven by the scaling of its battery materials, specialty carbon black, CNT, and SSCB businesses, alongside the expansion of Birla Tyres.
-
SBI, BEL Among Nine Stocks In HDFC Securities' Q2 Review; Sees Upside Of Up To 67%; Check New Target Prices
Based on HDFC Securities' target prices and closing prices, Eureka Forbes offers the highest potential upside of about 67%among the covered stocks, followed by SBI with 35% and , BEL with 30% and KEC International's target price implies a potential upside of 19%.
-
BEL Q2 Review: Motilal Oswal Lifts Target Price After Strong Beat; Check Target Price
BEL is also hopeful of a large order worth Rs 20,000 crore from next-generation corvettes, adds the brokerage.
-
Diwali Stock Picks 2026: SBI, Tech Mahindra Among Anand Rathi's Top Six Bets For Samvat 2083; Full List Inside
Ahead of Diwali, Anand Rathi has unveiled a basket of six stock picks spanning banking, IT, pharma, infrastructure, and metals and mining, betting on sector-specific growth drivers and attractive valuations.
-
Up To 87% Upside! HDFC Securities Lists 13 Stocks After Q2 Results; LIC Housing, Lodha, Syrma And More
The brokerage's latest assessment reflects a mixed earnings season, with healthy growth, improving operating performance and business expansion supporting some companies, while margin pressures, subdued demand and regulatory concerns continue to weigh on others.
-
Marico Q2 Review: Firing On All Cylinders; HDFC Securities Upgrades Rating; Check New Target Price
A refined strategy anchored in "fewer, bigger, bolder, and faster bets" is driving stronger growth momentum for Marico believes the brokearge.
-
ITC Q2 Review: FMCG Shines, Cigarette Business Drags; Motilal Oswal Retains Neutral Rating; Check Target Price
ITC is still in the transitory phase, with the full tax hike yet to be passed on to consumers, thus, the brokerage believe Cigarette's revenue and EBIT performance will be volatile in the near term.
-
Dixon Tech, Deepak Nitrite And More In Focus After Q2 Results: Check HDFC Securities Revised Target Prices, Upside
In retail-led real estate, Phoenix Mills continued to be rated Buy with an unchanged target price of Rs 2,104, supported by strong consumption trends, mall expansion and office leasing growth.
-
Interim Q2 Review: Strongest Earnings Growth In 12 Quarters As BFSI, Metals Drive Outperformance, Says Motilal Oswal
Earnings of the aforesaid 230 MOFSL Universe companies witnessed strong growth, demonstrating a broadbased outperformance across all key aggregates.
-
Ajanta Pharma Q2 Review: Stock Rally Limits Upside Despite Robust Performance, Says Systematix
The brokerage incorporates Ajanta Pharma's quarterly performance into its estimates and expect India to remain a key growth driver, supported by sustained outperformance against IPM, while factoring in normalisation in Africa institutional business.
-
Muthoot Q2 Review: Nirmal Bang Cautious Despite Earnings Resilience; Check Target Price
Muthoot should continue to deliver industry-leading profitability, with RoA of 5.65.8% and RoE of 26%, However, stabilising gold prices, elevated asset quality metrics, increase in funding costs with the rate hike cycle and intensifying competition in the gold loan segment are likely to limit further upside, says the brokerage.
-
Sun Pharma To Bank of Baroda Q2 Review: HDFC Securities Revises Target Prices, Retains Buy, Add Ratings On Eight Stocks; Details Inside
Among other stocks, the brokerage has retained a Buy rating on Sun Pharma with a revised target price of Rs 2,180, citing steady India business growth and expectations of recovery in its specialty portfolio.
-
Reliance Industries Q2 Review: Motilal Oswal Cuts Target Price Despite Strongest Ebitda In 17 Quarters; Here's Why
The brokerage raised its FY27E EBITDA and PAT by 8-10% and FY28 EBITDA and PAT by 4-7%, driven by improved profitability in the energy business and better margin delivery in Jio Platform.
-
IIM Ahmedabad Completes Summer Placements For 2026-28 Batch, Offers Over 230 Roles
IIM Ahmedabad completed summer placements for the 2026-28 PGP batch, offering over 230 roles across consulting, finance, consumer goods, and technology sectors.
-
Arvind Fashions To NALCO: Motilal Oswal Reviews Q2 Results Of Nine Stocks, Check Target Prices
Motilal Oswal Financial Services has reviewed the second-quarter earnings of nine companies across the textile, FMCG, metals and EPC sector including Gopal Snacks, Arvind Fashions, Ventive Hospitality, ConCor, Prataap Snacks, and more
-
Himadri Speciality Shares In Focus As Motilal Oswal Initiates Coverage, Sees Up To 47% Upside; Check Target Price
Motilal Oswal expects Himadri to deliver strong growth, driven by the scaling of its battery materials, specialty carbon black, CNT, and SSCB businesses, alongside the expansion of Birla Tyres.
-
SBI, BEL Among Nine Stocks In HDFC Securities' Q2 Review; Sees Upside Of Up To 67%; Check New Target Prices
Based on HDFC Securities' target prices and closing prices, Eureka Forbes offers the highest potential upside of about 67%among the covered stocks, followed by SBI with 35% and , BEL with 30% and KEC International's target price implies a potential upside of 19%.
-
BEL Q2 Review: Motilal Oswal Lifts Target Price After Strong Beat; Check Target Price
BEL is also hopeful of a large order worth Rs 20,000 crore from next-generation corvettes, adds the brokerage.
-
Diwali Stock Picks 2026: SBI, Tech Mahindra Among Anand Rathi's Top Six Bets For Samvat 2083; Full List Inside
Ahead of Diwali, Anand Rathi has unveiled a basket of six stock picks spanning banking, IT, pharma, infrastructure, and metals and mining, betting on sector-specific growth drivers and attractive valuations.
-
Up To 87% Upside! HDFC Securities Lists 13 Stocks After Q2 Results; LIC Housing, Lodha, Syrma And More
The brokerage's latest assessment reflects a mixed earnings season, with healthy growth, improving operating performance and business expansion supporting some companies, while margin pressures, subdued demand and regulatory concerns continue to weigh on others.
-
Marico Q2 Review: Firing On All Cylinders; HDFC Securities Upgrades Rating; Check New Target Price
A refined strategy anchored in "fewer, bigger, bolder, and faster bets" is driving stronger growth momentum for Marico believes the brokearge.
-
ITC Q2 Review: FMCG Shines, Cigarette Business Drags; Motilal Oswal Retains Neutral Rating; Check Target Price
ITC is still in the transitory phase, with the full tax hike yet to be passed on to consumers, thus, the brokerage believe Cigarette's revenue and EBIT performance will be volatile in the near term.
-
Dixon Tech, Deepak Nitrite And More In Focus After Q2 Results: Check HDFC Securities Revised Target Prices, Upside
In retail-led real estate, Phoenix Mills continued to be rated Buy with an unchanged target price of Rs 2,104, supported by strong consumption trends, mall expansion and office leasing growth.
-
Interim Q2 Review: Strongest Earnings Growth In 12 Quarters As BFSI, Metals Drive Outperformance, Says Motilal Oswal
Earnings of the aforesaid 230 MOFSL Universe companies witnessed strong growth, demonstrating a broadbased outperformance across all key aggregates.
-
Ajanta Pharma Q2 Review: Stock Rally Limits Upside Despite Robust Performance, Says Systematix
The brokerage incorporates Ajanta Pharma's quarterly performance into its estimates and expect India to remain a key growth driver, supported by sustained outperformance against IPM, while factoring in normalisation in Africa institutional business.
-
Muthoot Q2 Review: Nirmal Bang Cautious Despite Earnings Resilience; Check Target Price
Muthoot should continue to deliver industry-leading profitability, with RoA of 5.65.8% and RoE of 26%, However, stabilising gold prices, elevated asset quality metrics, increase in funding costs with the rate hike cycle and intensifying competition in the gold loan segment are likely to limit further upside, says the brokerage.
-
Sun Pharma To Bank of Baroda Q2 Review: HDFC Securities Revises Target Prices, Retains Buy, Add Ratings On Eight Stocks; Details Inside
Among other stocks, the brokerage has retained a Buy rating on Sun Pharma with a revised target price of Rs 2,180, citing steady India business growth and expectations of recovery in its specialty portfolio.
-
Reliance Industries Q2 Review: Motilal Oswal Cuts Target Price Despite Strongest Ebitda In 17 Quarters; Here's Why
The brokerage raised its FY27E EBITDA and PAT by 8-10% and FY28 EBITDA and PAT by 4-7%, driven by improved profitability in the energy business and better margin delivery in Jio Platform.
-
IIM Ahmedabad Completes Summer Placements For 2026-28 Batch, Offers Over 230 Roles
IIM Ahmedabad completed summer placements for the 2026-28 PGP batch, offering over 230 roles across consulting, finance, consumer goods, and technology sectors.
